To our knowledge, this is among the first studies to thoroughly examine the association between CTLA-4 gene polymorphisms and the risk and progression of HCV and HCC, in conjunction with circulating sCTLA-4 levels in the Egyptian population. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.